文献速递免疫规划传染病防控与疫情报告

乳酸乳球菌作为寄生虫疫苗递送平台:免疫途径与免疫结局的范围综述

Evaluating Lactococcus lactis as a novel antiparasitic vaccine delivery platform: A scoping review of immunization routes and immunological outcomes.
PubMed 文献 · Vaccine · 2026-03-17

本文为范围综述,检索多个数据库后纳入11项临床前研究,评估乳酸乳球菌递送原虫和蠕虫抗原的免疫应答与保护效果。接种可诱发Th1偏向应答,血清IgG见于8/11项研究、分泌型IgA见于5/11项,保护效果表现为寄生虫负荷或囊排出减少40%至71%等。免疫途径显著影响免疫谱与保护力。

要点

  • 乳酸乳球菌可诱导系统性及黏膜免疫,Th1偏向应答为主。
  • 血清IgG见于8/11项研究,分泌型IgA见于5/11项研究。
  • 保护效果包括寄生虫负荷或囊排出减少40%至71%。

核心结论

  • 乳酸乳球菌是能诱导系统与黏膜免疫的灵活抗原递送平台。
  • 免疫途径关键影响免疫谱和保护效果,需按病原类型和感染部位定制策略。

研究设计与样本

  • 范围综述,检索Medline/PubMed、Embase、Web of Science、Scopus、ScienceDirect和LILACS数据库。
  • 纳入11项符合标准的临床前研究,涵盖多种动物模型、给药途径、剂量和免疫程序。

主要发现

  • 原虫研究以利什曼原虫和疟原虫居多,贾第虫较少;报告抗原包括LACK、PpSP15、Hsp65、MSP1、MSA2、A2和CWP2。
  • 血清IgG(IgG1和IgG2a)在8/11项研究中检出,分泌型IgA在5/11项研究中检出。
  • 细胞应答常见IFN-γ升高,并伴IL-2、IL-4、IL-10、IL-12、IL-17调节及调节性T细胞扩增。
  • 保护效果范围为寄生虫负荷或囊排出减少40%至71%,还包括病变大小或爪肿胀减轻、生存改善或疟原虫血症降低。
  • 针对猪带绦虫和细粒棘球绦虫抗原(TSOL18和EG95),口服乳酸乳球菌疫苗诱导抗原特异性IgG及IgG亚类与细胞应答,减少寄生虫负荷。

临床怎么用

  • 临床前证据提示可依据病原类型、感染部位和期望免疫结局选择乳酸乳球菌疫苗的免疫途径。

局限性

  • 纳入研究数量有限(11项),动物模型、给药途径、剂量和免疫程序异质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lactococcus lactis has emerged as a versatile bacterial host for antigen delivery in vaccines against parasitic infections. This scoping review aimed to summarize preclinical studies employing L. lactis to deliver protozoan and helminth antigens, focusing on immune responses and protective efficacy. Comprehensive searches were conducted in electronic databases, including Medline/PubMed, Embase, Web of Science, Scopus, ScienceDirect, and LILACS. Eleven studies meeting eligibility criteria were included, encompassing diverse animal models, administration routes, doses, and immunization schedules. Among protozoa-targeting studies, Leishmania and Plasmodium species were most frequently investigated, whereas Giardia was less commonly studied. Reported antigens included LACK, PpSP15, Hsp65, MSP1, MSA2, A2, and CWP2. Vaccination elicited robust Th1-biased responses, with serum IgG (IgG1 and IgG2a) detected in 8/11 studies and secretory IgA in 5/11. Cellular responses commonly included increased IFN-γ, along with modulation of IL-2, IL-4, IL-10, IL-12, and IL-17, and expansion of regulatory T cells. Protective effects ranged from 40 to 71% reductions in parasitic load or cyst shedding, decreased lesion size or paw swelling, to improved survival or reduced parasitemia. In helminths, including Taenia solium and Echinococcus granulosus antigens (TSOL18 and EG95), oral L. lactis-based vaccines induced antigen-specific IgG and IgG subclasses, as well as cellular responses (IFN-γ, IL-4, IL-10), demonstrating efficacy in reducing parasite burden. Taken together, these findings highlight L. lactis as a flexible platform capable of inducing both systemic and mucosal immunity. The immunization route critically shapes the immune profile and protection, emphasizing the need to tailor vaccine strategies to pathogen type, infection site, and desired immune outcome. This review provides a comprehensive overview of current preclinical approaches and quantitative insights for optimizing L. lactis-based vaccines against parasitic diseases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rihs JB, Cirilo TM, Grossi de Oliveira AL, et al. Evaluating Lactococcus lactis as a novel antiparasitic vaccine delivery platform: A scoping review of immunization routes and immunological outcomes. Vaccine. 2026. PMID: 41849895. doi:10.1016/j.vaccine.2026.128431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。